Core Viewpoint - Shanghai Longyu Data Co., Ltd. (Longyu) has been severely penalized by regulators for significant financial fraud, including inflated revenue and profits over four consecutive years [2][6][10]. Summary by Sections Financial Misconduct - Longyu inflated its operating revenue and profits in its annual reports from 2019 to 2022, using fictitious trade chains and artificially increasing business links to conduct false trades in metals, oil products, and ethylene glycol [6][7]. - The inflated figures are as follows: - 2019: Revenue inflated by 2.242 billion, 16.61% of reported revenue; profit inflated by 5.73 million, 60.48% of reported profit [7]. - 2020: Revenue inflated by 3.986 billion, 44.57% of reported revenue; profit inflated by 11.1369 million, 10.36% of reported profit [7]. - 2021: Revenue inflated by 4.024 billion, 50.46% of reported revenue; profit inflated by 9.5195 million, 7.48% of reported profit [7]. - 2022: Revenue inflated by 4.288 billion, 42.95% of reported revenue; profit inflated by 10.9332 million, 23.92% of reported profit [7]. Non-Disclosure of Related Transactions - Longyu failed to disclose non-operating fund occupation related to transactions with 13 associated companies controlled by its actual controller, Xu Zengzeng, from June 2021 to November 2023 [8][9]. - The fund occupation amounts were: - 2022: 333 million, 9.19% of net assets [9]. - 2023: 875 million, 23.64% of net assets [9]. - 2024: 882 million, 26.53% of net assets [9]. Regulatory Actions - The China Securities Regulatory Commission (CSRC) proposed a fine of 11.5 million for Longyu and additional fines for responsible individuals, including Xu Zengzeng, who faces a 10-year market ban due to the severity of the violations [9][10]. - Longyu's stock was terminated from listing and will be transferred to the National SME Share Transfer System for management [12][13].

今年7月从沪市摘牌，退市龙宇依然要为其持续多年的财务造假和资金占用行为付出代价。 9月5日，上海证监局对退市龙宇作出行政处罚事先告知，因虚增收入利润，以及未按规定披露非经营性 资金占用相关关联交易等事项，退市龙宇及相关负责人被合计罚款3810万元。此前于2024年12月16日， 公司因涉嫌信息披露违法违规，被上海证监局立案调查。 因财务造假遭行政处罚 《行政处罚事先告知书》显示，退市龙宇在2019年至2022年虚增营业收入、利润，通过虚构贸易链条、 人为增加业务环节等方式，开展金属、油品、乙二醇等虚假贸易，公司2019年至2022年年度报告存在虚 假记载。 此外，2022年至2024年，退市龙宇实际控制人徐增增安排人员陆续成立并控制多家公司，且安排前述关 联公司充当供应商、客户等角色。公司对作为供应商的关联公司提前大比例或?额付款、对作为客户的 关联公司给予较长回款账期，由此构成非经营性资金占用相关关联交易。退市龙宇未及时披露上述非经 营性资金占用相关关联交易。 新"国九条"发布以来，监管机构严格执行退市制度，明确传达了"退市不免责"的监管导向。 对于公司相关问题，上海证监局于2024年4月29日对公司及责任 ...

Core Viewpoint - The regulatory authority has imposed significant penalties on Delisted Longyu for financial fraud, emphasizing a zero-tolerance policy towards such violations even after delisting [1][4][8]. Group 1: Regulatory Actions - Delisted Longyu received a total fine of 38.1 million yuan for financial misconduct from 2019 to 2022, including inflated revenues and profits through fictitious trade activities [1][4]. - The actual controller of Delisted Longyu has been banned from the securities market for ten years, alongside substantial fines imposed on other responsible individuals [5][6]. - The Shanghai Securities Regulatory Commission (SSRC) has initiated a thorough investigation into the company's illegal activities, demonstrating a commitment to accountability [4][8]. Group 2: Financial Misconduct Details - From 2019 to 2022, Delisted Longyu inflated its revenues by 2.242 billion yuan, 3.986 billion yuan, 4.024 billion yuan, and 4.288 billion yuan, representing 16.61%, 44.57%, 50.46%, and 42.95% of the reported revenues for those years, respectively [4]. - The company also reported inflated profits totaling 5.73 million yuan, 11.1369 million yuan, 9.5195 million yuan, and 10.9332 million yuan, which accounted for 60.48%, 10.36%, 7.48%, and 23.92% of the disclosed profits during the same period [4]. Group 3: Investor Protection and Market Integrity - The SSRC is actively working to recover losses for affected investors and has already facilitated the return of over 400 million yuan to Delisted Longyu [6]. - The regulatory body is committed to enhancing investor protection and maintaining a healthy market environment, reinforcing the importance of strict enforcement of delisting regulations [9].

Core Viewpoint - The regulatory authority demonstrates a "zero tolerance" approach towards financial fraud and misconduct by delisted companies, as evidenced by the severe penalties imposed on Delisted Longyu for its fraudulent activities from 2019 to 2022 [1][4][9]. Summary by Sections Regulatory Actions - Delisted Longyu received a notice of administrative penalty from the Shanghai Securities Regulatory Commission (SSRC), proposing a total fine of 38.1 million yuan for financial fraud and failure to disclose related party transactions [1][4]. - The SSRC has initiated investigations into Delisted Longyu's misconduct prior to its delisting, emphasizing a commitment to thorough investigations [3][4]. Financial Misconduct Details - From 2019 to 2022, Delisted Longyu inflated its revenue by 224.2 million yuan, 398.6 million yuan, 402.4 million yuan, and 428.8 million yuan, representing 16.61%, 44.57%, 50.46%, and 42.95% of the reported revenue for those years, respectively [4]. - The company also inflated its profit by 5.73 million yuan, 11.13 million yuan, 9.52 million yuan, and 10.93 million yuan, accounting for 60.48%, 10.36%, 7.48%, and 23.92% of the reported profit for the same periods [4]. Penalties and Accountability - The SSRC plans to impose a fine of 11.5 million yuan on Delisted Longyu and a fine of 16.9 million yuan on its actual controller, Xu Zengzeng, who will also face a ten-year ban from the securities market [6][7]. - Additional penalties totaling 9.7 million yuan will be levied against other responsible individuals, including the board of directors and financial executives [7]. Investor Protection and Market Integrity - The SSRC is actively working to recover losses for affected investors, having already facilitated the return of over 400 million yuan to Delisted Longyu from related parties [7]. - The actions taken against Delisted Longyu reflect the SSRC's commitment to enforcing strict delisting regulations and protecting investor rights, aiming to maintain a healthy market environment [9].

Core Viewpoint - The company *ST Zitian has been terminated from listing on the Shenzhen Stock Exchange due to financial misconduct, including false accounting reports and failure to rectify issues as mandated by regulatory authorities [1][4]. Group 1: Termination of Listing - On September 5, the Shenzhen Stock Exchange made a decision to terminate the listing of *ST Zitian [1]. - The company's stock will resume trading on September 15 and enter a delisting preparation period lasting 15 trading days, after which it will be delisted [4]. Group 2: Financial Misconduct - *ST Zitian has been found to have inflated revenues by a total of 24.99 billion yuan over two consecutive years, with significant discrepancies in three periodic reports [5]. - In the 2022 annual report, the company falsely reported internet advertising fees and other services, inflating revenue by 778 million yuan, which accounted for 44.59% of total revenue, and profit by 85 million yuan, representing 35.99% of total profit [6]. - The 2023 semi-annual report showed an inflated revenue of 208 million yuan and profit of 79 million yuan, which constituted 14.56% and 51.64% of total revenue and profit, respectively [6]. - The 2023 annual report indicated an inflated revenue of 1.721 billion yuan, making up 78.63% of total revenue, due to improper revenue recognition practices [6]. Group 3: Regulatory Actions and Penalties - The Fujian Securities Regulatory Bureau has imposed a total penalty of 38.4 million yuan on *ST Zitian and its management for the fraudulent activities and failure to disclose important information [6]. - The former chairman and CFO of the company have been banned from the securities market for life due to their roles in the misconduct [6]. - Legal actions have been initiated by investors for civil compensation, and criminal investigations have been launched regarding the company's accounting practices [7].

Core Viewpoint - *ST Zitian will resume trading on September 15 and enter a delisting arrangement period due to financial misconduct, including false accounting reports and failure to rectify issues as mandated by the China Securities Regulatory Commission (CSRC) [1][4]. Financial Misconduct - *ST Zitian inflated its revenue by a total of 2.499 billion yuan over two years, involving fraudulent activities in three periodic reports [3]. - In the 2022 annual report, the company falsely reported 778 million yuan in revenue and 85 million yuan in profit, which constituted 44.59% and 35.99% of the respective total revenue and profit [3]. - The 2023 semi-annual report showed an early recognition of 207 million yuan in revenue and 79 million yuan in profit, with the inflated profit accounting for 51.64% of the total profit for that period [3]. - The 2023 annual report indicated that a subsidiary inflated revenue by 1.721 billion yuan, representing 78.63% of the total revenue, by misapplying accounting methods [3]. Regulatory Actions - The CSRC imposed a total fine of 38.4 million yuan on *ST Zitian and 12 management personnel for their involvement in the financial fraud [4]. - The former chairman and CFO received lifetime bans from the securities market, reflecting the regulatory body's zero-tolerance stance on such misconduct [4]. Ongoing Accountability Measures - The delisting of *ST Zitian is not the end of accountability, as the CSRC has initiated comprehensive measures against those involved in the fraud [6]. - Investors have begun civil lawsuits to recover losses incurred due to the company's fraudulent activities, and criminal investigations are underway for potential accounting concealment crimes [6]. - The severity of the violations may lead to further criminal charges under laws related to the disclosure of important information [6].

Core Viewpoint - *ST Zitian has been ordered to delist from the Shenzhen Stock Exchange due to serious financial misconduct, including significant false reporting of revenues and profits, leading to a termination of its listing status [1][2][4]. Group 1: Company Background and Financial Misconduct - *ST Zitian, formerly known as Nantong Forging, transitioned to the advertising and media sector after a series of acquisitions and a name change in 2018 [2]. - The company was found to have inflated its revenue by 2.499 billion yuan through fraudulent activities, including fictitious SMS services and inflated internet advertising fees [2][3]. - In 2022, the company reported inflated revenue of 778 million yuan, which constituted 44.59% of its disclosed revenue, and inflated profits of 85 million yuan, making up 35.99% of total profits [3]. - For the first half of 2023, *ST Zitian prematurely recognized revenue of 207 million yuan, representing 14.56% of that period's revenue, and inflated profits of 79 million yuan, accounting for 51.64% of total profits [3]. - The 2023 annual report showed inflated revenue of 1.721 billion yuan, which was 78.63% of the reported revenue, due to improper revenue recognition methods [3]. Group 2: Regulatory Actions and Consequences - The Shenzhen Stock Exchange issued a notice of termination of listing due to the company's failure to rectify its financial reports within the required timeframe [1][4]. - The company faced administrative penalties from the Fujian Securities Regulatory Bureau, with fines totaling 38.4 million yuan imposed on 12 members of the management team, including lifetime bans for the former chairman and CFO [4]. - Regulatory bodies are adopting a "zero tolerance" approach towards financial fraud, emphasizing comprehensive accountability for perpetrators, including civil, administrative, and criminal liabilities [5][6]. - Investors have initiated civil lawsuits against *ST Zitian, and criminal investigations are underway for potential accounting concealment and other violations [6].

Core Viewpoint - *ST Zitian will resume trading on September 15 and enter a delisting arrangement period due to financial misconduct, including false accounting reports and failure to rectify issues as mandated by the China Securities Regulatory Commission (CSRC) [2][5] Group 1: Financial Misconduct - *ST Zitian inflated its revenue by a total of 2.499 billion yuan over two years, involving fraudulent activities in three periodic reports [4] - In the 2022 annual report, the company falsely reported 778 million yuan in revenue and 85 million yuan in profit, which accounted for 44.59% and 35.99% of total revenue and profit, respectively [4] - The 2023 semi-annual report showed an early recognition of 207 million yuan in revenue and 79 million yuan in profit, with the inflated profit representing 51.64% of the total profit for that period [4] - The company misused the gross method for revenue recognition instead of the net method, leading to an inflated revenue of 1.721 billion yuan, which constituted 78.63% of the reported revenue for that period [4] Group 2: Regulatory Actions and Penalties - The CSRC imposed a total fine of 38.4 million yuan on *ST Zitian and 12 of its management personnel for the financial misconduct [5] - The former chairman and CFO of the company received lifetime bans from the securities market, highlighting the regulatory body's zero-tolerance approach [5] - The Shenzhen Stock Exchange confirmed that *ST Zitian's failure to rectify its financial reports within the required timeframe led to the inevitable delisting of its shares [5] Group 3: Ongoing Legal and Regulatory Consequences - Legal actions are underway, with investors filing civil compensation lawsuits to recover losses incurred due to the company's fraudulent activities [7] - The police have initiated an investigation into *ST Zitian for suspected "concealment of accounting vouchers," indicating potential criminal liability [7] - The case serves as a warning to the capital market that financial fraud can lead to severe consequences, including delisting and criminal prosecution for responsible individuals [7]

Core Viewpoint - *ST Zitian will resume trading on September 15 and enter a delisting arrangement period due to financial fraud and failure to rectify issues as mandated by the China Securities Regulatory Commission (CSRC) [1][4]. Group 1: Financial Fraud Details - *ST Zitian inflated its revenue by a total of 2.499 billion yuan over two years, involving fraudulent activities in three periodic reports [3]. - In the 2022 annual report, the company falsely reported 778 million yuan in revenue and 85 million yuan in profit, which constituted 44.59% and 35.99% of the respective total revenue and profit [3]. - The 2023 semi-annual report showed an early recognition of 207 million yuan in revenue and 79 million yuan in profit, with the inflated profit accounting for 51.64% of the total profit for that period [3]. - The 2023 annual report indicated that a subsidiary inflated revenue by 1.721 billion yuan, representing 78.63% of the total revenue, by misapplying accounting methods [3]. Group 2: Regulatory Actions and Penalties - The CSRC imposed a total fine of 38.4 million yuan on *ST Zitian and 12 management personnel for various violations, including financial fraud and failure to disclose the 2024 annual report on time [4]. - The former chairman and CFO received lifetime bans from the securities market, highlighting the regulatory body's zero-tolerance approach to financial misconduct [4]. Group 3: Ongoing Accountability Measures - The delisting of *ST Zitian is not the end of accountability, as the CSRC has initiated comprehensive measures against those involved in the fraud [6]. - Investors have begun filing civil lawsuits to recover losses incurred due to the company's fraudulent activities [6]. - Law enforcement has opened a criminal investigation into *ST Zitian for suspected accounting document concealment, with potential further criminal charges for serious violations [6].

Core Viewpoint - Huaxi Biological (688363.SH) reported a significant decline in financial performance for the first half of 2025, with revenue and net profit both experiencing substantial year-on-year decreases [1][2][3]. Financial Performance Summary - The company achieved operating revenue of 2.261 billion RMB in the first half of 2025, a decrease of 19.57% compared to the same period last year [1][2]. - Net profit attributable to shareholders was 221 million RMB, down 35.38% year-on-year [1][2]. - The net profit after deducting non-recurring gains and losses was 174 million RMB, reflecting a 45.00% decline [1][2]. - The net cash flow from operating activities was 218 million RMB, showing an increase of 17.49% compared to the previous year [2]. Historical Performance Trends - From 2022 to 2024, the company's net profit has consistently declined, with figures of 970 million RMB, 593 million RMB, and 174 million RMB respectively [2]. - The net profit after deducting non-recurring gains and losses also decreased from 852 million RMB in 2022 to 107 million RMB in 2024 [2]. Management Changes and Corporate Governance - In March 2025, founder Zhao Yan returned to the frontline, initiating significant reforms in the company's operational philosophy, business direction, and talent organization [3]. - Zhao Yan implemented strict anti-corruption measures, demanding all involved personnel to report issues and submit resignations by March 31 [3]. - The management team has seen considerable turnover, with 11 executives leaving since the beginning of the year, including the former chief scientist and vice presidents [4]. Allegations and Legal Matters - A former employee accused Huaxi Biological of financial fraud, which the company has firmly denied, labeling the claims as fabricated and malicious [4]. - The company has reported the allegations to law enforcement, and the investigation is ongoing [4].